Cargando…

MON-565 Patients Thyroidectomized For Thyroid Cancer (without Malabsorption) In Treatment With Oral Liquid L-thyroxine (L-T4) Formulation

We aimed to study the efficacy of levothyroxine (L-T4) liquid formulation in comparison to L-T4 tablets, in patients recently submitted to total thyroidectomy, without malabsorption or drug interference issues. In this study 140 patients were included: 70 received liquid L-T4 formulation; 70 took L-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fallahi, Poupak, Ferrari, Silvia Martina, Ruffilli, Ilaria, Ragusa, Francesca, Materazzi, Gabriele, Miccoli, Paolo, Antonelli, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550645/ http://dx.doi.org/10.1210/js.2019-MON-565

Ejemplares similares

MON-564 Patients Thyroidectomized For Thyroid Cancer (without Malabsorption) In Treatment With L-thyroxine (L-T4) In Soft Gel Capsule Formulation
por: Fallahi, Poupak, et al.
Publicado: (2019)

Oral L‐thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study
por: Fallahi, Poupak, et al.
Publicado: (2018)

MON-566 Early Diagnosis of Lymph Node Metastases by Serum Tg and Neck Ultrasonography, and Long Term Follow Up After Radioiodine and/or Surgical Treatment in Patients with Papillary or Follicular Thyroid Cancer.
por: Fallahi, Poupak, et al.
Publicado: (2019)

FRI487 Oral Liquid L- Thyroxine (L-T4) Is More Effective In Controlling Hypothyroidism, Than L-T4 Tablet, In Patients Submitted To Total Thyroidectomy
por: Fallahi, Poupak, et al.
Publicado: (2023)

Oral Liquid L-Thyroxine (L-T4) May Be Better Absorbed in Comparison to L-T4 Tablets in Patients With Lactose Intolerance
por: Fallahi, Poupak, et al.
Publicado: (2021)

MON-625 Serum Tsh Levels Normalisation In Patients With Celiac Disease After The Switch From Oral L-t4 In Tablet Form To L-t4 In Liquid Formulation
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

MON-LB102 Liquid L-Thyroxine Can Maintain Stable TSH Values in Patients with Hypothyroidism: A Prospective Study
por: Fallahi, Poupak, et al.
Publicado: (2019)

PSAT366 Liquid L-thyroxine (L-T4) Formulation Normalizes TSH in Hypothyroid Patients Treated with Tablets L-T4
por: Antonelli, Alessandro, et al.
Publicado: (2022)

MON-594 Report Of A Large Series Of Patients With Graves' Disease (with/without Graves' Ophthalmopathy) And Review Of The Literature, About The Association With Other Autoimmune Diseases
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

The Synergistic Effect of Corticosteroids and Mycophenolic Acid on Chemokines in Orbital Cells From Patients With Graves’ Ophthalmopathy
por: Fallahi, Poupak, et al.
Publicado: (2021)

L-T4 Therapy in Enteric Malabsorptive Disorders
por: Fallahi, Poupak, et al.
Publicado: (2021)

ODP598 Liquid levothyroxine (L-T4) maintains more stable TSH levels in hypothyroid patients, than tablet L-T4
por: Antonelli, Alessandro, et al.
Publicado: (2022)

Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series
por: Fallahi, Poupak, et al.
Publicado: (2016)

SUN-590 Failure to Control Severe Hypothyroidism with L-Thyroxine Tablets Corrected by Switching to Oral Soft Gel Formulation
por: Solhjoo, Mahdis, et al.
Publicado: (2019)

FRI530 Immune-Modulation By Rapamycin, Or Mycophenolic Acid, Of Th1 And Th2 Chemokines Secretion In Retro-orbital Cells Of Patients With Graves’ Ophthalmopathy
por: Elia, Giusy, et al.
Publicado: (2023)

MON-602 Improving The Accuracy And Reliability Of Free Thyroxine Measurements Through The CDC Clinical Standardization Programs
por: Ribera, Ashley, et al.
Publicado: (2019)

MON-604 Reference Ranges for Thyroid Stimulating Hormone and Free Thyroxine in an Older Rural South African Population
por: Wade, Alisha, et al.
Publicado: (2019)

SAT-509 Sudden Onset of Malabsorption
por: Mroueh, Gabriela, et al.
Publicado: (2020)

RF23 | PSAT365 An Open-Label Therapeutic Efficacy Study of Tirosint (Levothyroxine Sodium) Capsules in Thyroidectomized Patients Taking Proton Pump Inhibitors
por: Sachmechi, Issac, et al.
Publicado: (2022)

Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
por: Fallahi, Poupak, et al.
Publicado: (2019)

SUN-565 Do Over-the-Counter Energy Supplements Delay the Diagnosis of Graves' Disease?
por: Sandhu, Harjyot, et al.
Publicado: (2019)

SAT565 Is Firefighting An Occupational Risk For Papillary Thyroid Cancer? A Case Report
por: Diamond-Rossi, Samantha Anne, et al.
Publicado: (2023)

Evaluation of the Optimal Thyroxine Levels for Thyroxine Hormone Replacement in Patients With Central Hypothyroidism
por: Lee, Ka Fai, et al.
Publicado: (2021)

Alteration of Serum Proteome in Levo-Thyroxine-Euthyroid Thyroidectomized Patients
por: Landi, Claudia, et al.
Publicado: (2022)

FRI565 Spontaneous Conversion Of Long-standing Hypothyroidism To Grave’s Disease: A Case Report
por: Rose Dominic, Maria, et al.
Publicado: (2023)

SUN-549 Erratic Medication-Related Malabsorption of L-T4 Associated with Highly Elevated TSH Levels in a Patient with Renal Tubular Acidosis, Thyrotroph Hyperplasia, and Hashimoto's Thyroiditis
por: Sandhu, Harjyot, et al.
Publicado: (2019)

Thyroxine Treatment With Softgel Capsule Formulation: Usefulness in Hypothyroid Patients Without Malabsorption
por: Trimboli, Pierpaolo, et al.
Publicado: (2018)

MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis?
por: Giani, Carlotta, et al.
Publicado: (2020)

SAT-483 Levothyroxine Absorption Test: A Potential Therapeutic Tool for Levothyroxine Malabsorption
por: Arora, Tanureet, et al.
Publicado: (2020)

MON-601 Optimizing the Mean TSH Target Range for Thyroid Hormone (L-T4) Replacement in Primary Hypothyroidism
por: Siddiqui, Mahwash, et al.
Publicado: (2019)

MON-465 Novel Thyroid Hormone β Mutation L266s Causes Atrial Fibrillation & Cerebral Infarction
por: Ono, Wataru, et al.
Publicado: (2020)

The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine
por: Antonelli, Alessandro, et al.
Publicado: (2021)

New Targeted Therapies for Thyroid Cancer
por: Antonelli, Alessandro, et al.
Publicado: (2011)

SAT-553 Gut Microbiota Involved in Thyroxine Metabolism and Development of Subclinical Hypothyroidism
por: Bo, Tao, et al.
Publicado: (2019)

Molecular Targeted Therapies of Aggressive Thyroid Cancer
por: Ferrari, Silvia Martina, et al.
Publicado: (2015)

Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity
por: Ruffilli, Ilaria, et al.
Publicado: (2017)

SAT-565 The Surface Of Liganded T3 Receptor β2 For Steroid Receptor Coactivator 1 And 2 Mediates The Negative Regulation Of The Prepro-thyrotropin-releasing Hormone Gene By T3
por: Sakai, Yuki, et al.
Publicado: (2019)

ODP511 Relationship between TSH and Free Thyroxine in Outpatient Cancer Patient Population
por: Li, Jieli, et al.
Publicado: (2022)

FRI527 Timing Of Thyroxine Dose During Ramadan: A Randomized Controlled Trial
por: Mohammad Alamoudi, Reem, et al.
Publicado: (2023)

PSAT364 High-Dose Levothyroxine to Exclude Malabsorption as a Cause of Refractory Hypothyroidism in Hospitalized Patients: Two Cases
por: Majumdar, Sachin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jt0rsjf0b20v3utmqeotrd85ug